Healthtech AI startup, Endimension Technology raises INR 6 Crore in Pre-Series A round led by Inflection Point Ventures
- Round also saw
participation from SucSeed Indovation and SINE IIT-B
- Endimension
is a healthcare AI startup that provides accurate and early diagnosis of diseases from radiology scans.
- Funds raised to be utilized
for research and development, team expansion, software development and sales
enhancement
- Endimension's
platform has conducted over 1 million patient scans and is present in 400
hospitals and diagnostic centers spanning various regions, thereby improving
their accessibility
- So far, Inflection Point Ventures has invested over INR 700 Cr across 250+ startups
Mumbai, 25th April 2024- Endimension Technology, a healthcare AI
startup has raised INR 6 Crore in Pre-Series A round led by Inflection Point
Ventures. Other investors in this round include Sucseed Indovation, SINE IIT
Bombay and individual angel investors. Endimension Technology, incubated at IIT Bombay, is
driven by the vision to harness AI technology in radiology, ensuring early and
precise diagnosis for patients globally.
The funds will be utilized to fuel AI
research and development, team expansion, software enhancement. These strategic
investments aim to bolster their market position, accelerate growth, and
establish Endimension as an industry leader.
Endimension is backed by leaders with immense experience in technology and
artificial intelligence. Bharadwaj Kss, Founder & CEO, holds a bachelor’s
from IIT Madras and a master’s from IIT Bombay. He has 10 years of experience
in Artificial Intelligence & Machine Learning. Apparao Mlv, co-founder
& COO, has 10 years of operational and marketing experience. He holds a bachelor’s
in technology from ICT Mumbai. Karthik Kannegondla is the Chief Technology
Officer and brings 10 years of software development experience to the table
along with his B.Tech and M.Tech from IIT Madras.
Ivy
Chin, Partner, Inflection Point Ventures says, “The Indian radio-diagnosis market, growing at a CAGR of 15%+ over the
last decade, has got a lot of focus on equipment & infrastructure. The
under-stated need is that of qualified professionals, i.e. radiologists, to
manage this burgeoning demand. There has been growth across tier 1, 2 & 3
for equipment but the availability and prohibitive costs of trained
radiologists exacerbates the problem of demand outstripping supply situation.
Endimension focuses on leveraging AI to facilitate faster assessment and
diagnosis, employing generative AI to streamline report generation and reduce
the time required by radiologists. IPV is confident that this investment will contribute towards the
betterment of the industry”.
The
global market for AI in medical imaging is expected to grow significantly in
the coming years. In 2024, the market size is estimated to be around USD 5.86
billion and is projected to reach USD 20.40 billion by 2029, with a compound
annual growth rate (CAGR) of 28.32%? (Ref: Mordor Intelli)?. This growth is
driven by the increasing demand for early and accurate diagnosis, the rising
awareness about chronic diseases requiring imaging services, and the growing
adoption of AI technologies in healthcare. Capitalizing on this, Endimension
has established itself as an end-to-end AI platform for radiology diagnosis,
distinguished by its seamless integration, multiple customization options, and
ability to diagnose a wide range of conditions with precision, leading to
improved patient outcomes. Endimension’s platform has processed over 1 million
scans to date and is currently deployed in 400 hospitals and diagnostic centres
across multiple regions, enhancing their accessibility.
Endimension has added several feathers to its cap over the years. The startup was one of the 20 startups selected by Google for Startup Accelerator Class 8 and one of the top 10 startups at the WhatsApp Incubator Programme. They received the Life Science Award at Asian Entrepreneurship Awards. They were winners at SIDBI Investors Day event and have also won the NASSCOM Healthcare Innovation Challenge. Endimension has also been supported and recognised by the Department of Biotechnology, Government of India.
About Endimension Technology
Endimension Technology is a pioneering technology company specializing in
AI-driven solutions for radiology diagnostics. Their end-to-end AI platform
enhances radiologist efficiency and accuracy by streamlining diagnostic
processes and improving detection rates. With over 1 million patient scans
processed and deployment in 400+ hospitals and diagnostic centres worldwide,
Endimension is at the forefront of revolutionizing radiology and improving
global healthcare standards.
About Inflection Point Ventures and Physis
Capital
Inflection Point Ventures (IPV)
is an angel investing platform with over 14,000+ CXOs, HNIs, and Professionals
to together invest in startups. The firm supports new-age entrepreneurs by
providing them with monetary & experiential capital and connecting them
with a diverse group of investors. IPV has announced the launch of a $50
million CAT 2 AIF, Physis Capital, to invest in pre-Series A to Series B
growth-stage start-ups.